Cited by 388Posttraumatic Stress Disorder ResearchVirtual Reality Applications and ImpactsPsychotherapy Techniques and Applications

A Randomized, Double-Blind Evaluation of d -Cycloserine or Alprazolam Combined With Virtual Reality Exposure Therapy for Posttraumatic Stress Disorder in Iraq and Afghanistan War Veterans

Open access
Rothbaum, Barbara Olasov, Price, Matthew, Jovanovic, Tanja, Norrholm, Seth D., Gerardi, Maryrose, Dunlop, Boadie, Davis, Michael, Bradley, Bekh +3 more·2014·American Journal of Psychiatry

Abstract

OBJECTIVE: The authors examined the effectiveness of virtual reality exposure augmented with D-cycloserine or alprazolam, compared with placebo, in reducing posttraumatic stress disorder (PTSD) due to military trauma. METHOD: After an introductory session, five sessions of virtual reality exposure were augmented with D-cycloserine (50 mg) or alprazolam (0.25 mg) in a double-blind, placebo-controlled randomized clinical trial for 156 Iraq and Afghanistan war veterans with PTSD. RESULTS: PTSD symptoms significantly improved from pre- to posttreatment across all conditions and were maintained at 3, 6, and 12 months. There were no overall differences in symptoms between D-cycloserine and placebo at any time. Alprazolam and placebo differed significantly on the Clinician-Administered PTSD Scale score at posttreatment and PTSD diagnosis at 3 months posttreatment; the alprazolam group showed a higher rate of PTSD (82.8%) than the placebo group (47.8%). Between-session extinction learning was a treatment-specific enhancer of outcome for the D-cycloserine group only. At posttreatment, the D-cycloserine group had the lowest cortisol reactivity and smallest startle response during virtual reality scenes. CONCLUSIONS: A six-session virtual reality treatment was associated with reduction in PTSD diagnoses and symptoms in Iraq and Afghanistan veterans, although there was no control condition for the virtual reality exposure. There was no advantage of D-cycloserine for PTSD symptoms in primary analyses. In secondary analyses, alprazolam impaired recovery and D-cycloserine enhanced virtual reality outcome in patients who demonstrated within-session learning. D-cycloserine augmentation reduced cortisol and startle reactivity more than did alprazolam or placebo, findings that are consistent with those in the animal literature.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2014.13121625

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • D-cycloserine administered with VRET for PTSD patients has been proven effective in reducing PTSD symptoms.

    “VRET has also been augmented pharmacologically by administering D-cycloserine with VRET for PTSD patients. This combination has been proven effective in reducing PTSD symptoms (Rothbaum et al., 2014; Difede et al., 2014)”

    From Virtual Reality exposure therapy in the treatment of public speaking anxiety and social anxiety disorder (2024) · cites this paper as Rothbaum et al., 2014

    The Abstract Results report that PTSD symptoms improved during VRE across all treatment groups, including the D-cycloserine group. But they found no overall symptom advantage for D-cycloserine, and the Discussion calls its enhancement of VRE inconclusive. Because there was no VRE-only control, this paper does not establish that the combination itself was effective. (LLM, conf=0.89)

    Experimental — accuracy not yet measured
  • Clinically, individuals with PTSD have been shown to have alterations in stimulus generalization, fear inhibition, discrimination, and fear extinction.

    “Clinically, individuals with PTSD have been show to have alterations in stimulus generalization (16), fear inhibition (29), discrimination, and fear extinction (38).”
  • Trauma imagery-potentiated startle responses in recently returned combat veterans from Iraq and Afghanistan were significantly reduced in individuals who previously received DCS before each of five sessions of virtual reality exposure therapy for PTSD.

    “Finally, trauma imagery-potentiated startle responses in recently returned combat veterans from Iraq and Afghanistan were significantly reduced in individuals who previously received DCS before each of five sessions of virtual reality exposure therapy for PTSD (38).”
  • Trials of D-cycloserine to augment exposure therapy for PTSD have yielded mixed results: one found faster symptom reduction, one found a detrimental effect, and three found no effect.

    “One study found evidence of a faster rate of symptom reduction 141 , while another reported a detrimental effect 142 , and three further trials found no effect 143-145 .”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [1]Institute of Medicine (IOM) Treatment for posttraumatic stress disorder in military and veteran populations: initial assessment 2012 Washington, DC The National Academies Press Preface 24830058
  2. [3]Institute of Medicine (IOM) Treatment of posttraumatic stress disorder: an assessment of the evidence 2008 Washington, DC The National Academies Press
  3. [7]Foa EB Rothbaum BO Treating the Trauma of Rape: Cognitive-Behavior Therapy for PTSD 1998 New York Guilford Press

Cited by

Sorted by citations

Authors
Rothbaum, B. O., Price, M., Jovanovic, T., Norrholm, S. D., Gerardi, M., Dunlop, B., Davis, M., Bradley, B., Duncan, E. J., Rizzo, A., & Ressler, K. J.
Affiliations
  • University of Vermont (US)
  • From the Trauma and Anxiety Recovery Program and the Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta; the Trauma Recovery Program and Mental Health Service, Department of Veterans Affairs Medical Center, Atlanta; the Department of Psychology, University of Vermont, Burlington; the Howard Hughes Medical Institute, Chevy Chase, Md.; and the Institute for Creative Technologies and the Department of Psychiatry and Behavioral Sciences, University of Southern...
Venue
American Journal of Psychiatry
Published
2014-06
Volume
171
Issue
6
Pages
640-648
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2160848506
Cited by
388
References
36
Citations by year
2026: 8 · 2025: 12 · 2024: 23 · 2023: 26 · 2022: 36 · 2021: 33 · 2020: 29 · 2019: 43 · 2018: 45 · 2017: 48 · 2016: 27 · 2015: 38 · 2014: 20
FWCI
52.06
Type
journal article
Language
en
Open access
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Defense (W81XWH, W81XWH1011045)
  • McCormick Foundation
  • Pfizer
  • Emory University
  • National Alliance for Research on Schizophrenia and Depression
  • University of Oxford
  • National Institutes of Health (5u19mh069056-10, W81XWH)
  • Genentech
  • National Institute of Mental Health (U19-MH069056, 1R01MH70880-01-A2, R01MH094757, R01MH070880)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Physical Sciences › Computer Science › Human-Computer Interaction › Virtual Reality Applications and Impacts
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
Keywords
post-traumatic stress disorder, virtual reality exposure therapy, D-cycloserine, alprazolam, Iraq and Afghanistan veterans, military trauma, extinction learning, cortisol response, startle response, drug augmentation, PTSD treatment outcomes
MeSH terms
Adult, Alprazolam, Combined Modality Therapy, Cycloserine, Double-Blind Method, Extinction, Psychological, Female, Humans, Male, Psychiatric Status Rating Scales, Stress Disorders, Post-Traumatic, Anti-Anxiety Agents, Veterans, Treatment Outcome, Iraq War, 2003-2011, Afghan Campaign 2001-, Virtual Reality Exposure Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review